Stocks News

LAST PRICE
162.2500
TODAY'S CHANGE (%)
Trending Down-1.5400 (-0.9402%)

Bid / Lots
162.2300/ 1
Ask / Lots
162.2700/ 3
Open / Previous Close
164.4100 / 163.7900
Day Range
Low 161.0000
High 164.6346
52 Week Range
Low 130.9601
High 182.8900
Volume
3,465,562
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Today
- AbbVie to Present at the Bank of America Securities Healthcare Conference, from 7 hours ago by Dow Jones
  7 hours ago by Dow Jones
  Companies Mentioned: ABBV
  
  AbbVie to Present at the Bank of America Securities Healthcare Conference
  
  PR Newswire
  
  NORTH CHICAGO, Ill., May 6, 2024
  
  NORTH CHICAGO, Ill., May 6, 2024 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Bank of America Securities Healthcare Conference on Wednesday, May 15, 2024. Robert A. Michael, president and chief operating officer, Scott T. Reents, executive vice president, chief financial officer, Jeffrey R. Stewart, executive vice president, chief commercial officer and Roopal Thakkar, M.D., senior vice president, chief medical officer, global therapeutics, will present at 12:40 p.m. Central time.
Apr 29, 2024
- DJ AbbVie Is Maintained at Overweight by Barclays, from 11:36AM ET on Monday Apr 29, 2024 by Dow Jones
  11:36AM ET on Monday Apr 29, 2024 by Dow Jones
  Companies Mentioned: ABBV
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/ABBV/analyst-ratings
  
  (END) Dow Jones Newswires
  
  April 29, 2024 11:36 ET (15:36 GMT)
- BMO Capital Cuts Price Target on AbbVie to $180 From $195, Maintains Outperform Rating, from 11:24AM ET on Monday Apr 29, 2024 by MT Newswires
  11:24AM ET on Monday Apr 29, 2024 by MT Newswires
  Companies Mentioned: ABBV
  11:24 AM EDT, 04/29/2024 (MT Newswires) -- AbbVie (ABBV) has an average outperform rating and a price target range of $161 to $206, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic research from major b...
- DJ AbbVie Is Maintained at Outperform by BMO Capital, from 10:19AM ET on Monday Apr 29, 2024 by Dow Jones
  10:19AM ET on Monday Apr 29, 2024 by Dow Jones
  Companies Mentioned: ABBV
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/ABBV/analyst-ratings
  
  (END) Dow Jones Newswires
  
  April 29, 2024 10:19 ET (14:19 GMT)
- Morgan Stanley Adjusts AbbVie's Price Target to $191 From $196, from 8:37AM ET on Monday Apr 29, 2024 by MT Newswires
  8:37AM ET on Monday Apr 29, 2024 by MT Newswires
  Companies Mentioned: ABBV
  08:37 AM EDT, 04/29/2024 (MT Newswires) -- AbbVie (ABBV) has an average rating of outperform and price targets ranging from $161 to $206, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic research from m...

Today
- Pfizer Names Andrew Baum as Chief Strategy, Innovation Officer, from 7 hours ago by MT Newswires
  7 hours ago by MT Newswires
  Companies Mentioned: PFE
- Cellectis Secures $140 Million Additional Equity Investment From AstraZeneca, from 11 hours ago by MT Newswires
  11 hours ago by MT Newswires
  Companies Mentioned: AZN, CLLS
- Cellectis Announces Completion of the Additional Equity Investment by AstraZeneca, from 13 hours ago by GlobeNewswire
  13 hours ago by GlobeNewswire
  Companies Mentioned: AZN, CLLS
May 3, 2024
- Top Five Cancer Types Dominate New US Cases as Biotech Sector Eyes $314B Market by 2032, from 12:15PM ET on Friday May 03, 2024 by CNW Group
  12:15PM ET on Friday May 03, 2024 by CNW Group
  Companies Mentioned: ONCY, CELC, AZN, BIO, OLMA
- Top Five Cancer Types Dominate New US Cases as Biotech Sector Eyes $314B Market by 2032, from 12:15PM ET on Friday May 03, 2024 by PR Newswire
  12:15PM ET on Friday May 03, 2024 by PR Newswire
  Companies Mentioned: ONCY, CELC, AZN, BIO, OLMA
May 2, 2024
- Sector Update: Health Care Stocks Softer Late Afternoon, from 3:58PM ET on Thursday May 02, 2024 by MT Newswires
  3:58PM ET on Thursday May 02, 2024 by MT Newswires
  Companies Mentioned: NVO, NVS, MRNA, EBS
- Sector Update: Health Care Stocks Retreat Thursday Afternoon, from 1:59PM ET on Thursday May 02, 2024 by MT Newswires
  1:59PM ET on Thursday May 02, 2024 by MT Newswires
  Companies Mentioned: NVO, NVS, MRNA
- AstraZeneca Says Calquence Combination Improves Progression-Free Survival in Phase 3 Mantle Cell Lymphoma Trial, from 11:02AM ET on Thursday May 02, 2024 by MT Newswires
  11:02AM ET on Thursday May 02, 2024 by MT Newswires
  Companies Mentioned: AZN
- Update: Novartis AG to Acquire Mariana Oncology in Deal Valued Up to $1.75 Billion., from 10:30AM ET on Thursday May 02, 2024 by MT Newswires
  10:30AM ET on Thursday May 02, 2024 by MT Newswires
  Companies Mentioned: NVS
- Morgan Stanley Adjusts Price Target on Pfizer to $29 From $28, from 10:09AM ET on Thursday May 02, 2024 by MT Newswires
  10:09AM ET on Thursday May 02, 2024 by MT Newswires
  Companies Mentioned: PFE

AbbVie Inc
NYSE:ABBVUnited States

Search Criteria

Today

AbbVie to Present at the Bank of America Securities Healthcare Conference, from 7 hours ago by Dow Jones

Apr 29, 2024

DJ AbbVie Is Maintained at Overweight by Barclays, from 11:36AM ET on Monday Apr 29, 2024 by Dow Jones

BMO Capital Cuts Price Target on AbbVie to $180 From $195, Maintains Outperform Rating, from 11:24AM ET on Monday Apr 29, 2024 by MT Newswires

DJ AbbVie Is Maintained at Outperform by BMO Capital, from 10:19AM ET on Monday Apr 29, 2024 by Dow Jones

Morgan Stanley Adjusts AbbVie's Price Target to $191 From $196, from 8:37AM ET on Monday Apr 29, 2024 by MT Newswires

Peers Headlines

Today

Pfizer Names Andrew Baum as Chief Strategy, Innovation Officer, from 7 hours ago by MT Newswires

Cellectis Secures $140 Million Additional Equity Investment From AstraZeneca, from 11 hours ago by MT Newswires

Cellectis Announces Completion of the Additional Equity Investment by AstraZeneca, from 13 hours ago by GlobeNewswire

May 3, 2024

Top Five Cancer Types Dominate New US Cases as Biotech Sector Eyes $314B Market by 2032, from 12:15PM ET on Friday May 03, 2024 by CNW Group

Top Five Cancer Types Dominate New US Cases as Biotech Sector Eyes $314B Market by 2032, from 12:15PM ET on Friday May 03, 2024 by PR Newswire

May 2, 2024

Sector Update: Health Care Stocks Softer Late Afternoon, from 3:58PM ET on Thursday May 02, 2024 by MT Newswires

Sector Update: Health Care Stocks Retreat Thursday Afternoon, from 1:59PM ET on Thursday May 02, 2024 by MT Newswires

AstraZeneca Says Calquence Combination Improves Progression-Free Survival in Phase 3 Mantle Cell Lymphoma Trial, from 11:02AM ET on Thursday May 02, 2024 by MT Newswires

Update: Novartis AG to Acquire Mariana Oncology in Deal Valued Up to $1.75 Billion., from 10:30AM ET on Thursday May 02, 2024 by MT Newswires

Morgan Stanley Adjusts Price Target on Pfizer to $29 From $28, from 10:09AM ET on Thursday May 02, 2024 by MT Newswires